147 related articles for article (PubMed ID: 38573397)
1. Vitamin D
Zhang M; Chen L; Xu Q; Yang X; Liu X; Liu L
In Vitro Cell Dev Biol Anim; 2024 Apr; 60(4):432-440. PubMed ID: 38573397
[TBL] [Abstract][Full Text] [Related]
2. Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys.
Bishop CV; Lee DM; Slayden OD; Li X
J Ovarian Res; 2017 Jul; 10(1):41. PubMed ID: 28683759
[TBL] [Abstract][Full Text] [Related]
3. GnRH Agonist Triggering Modulates PEDF to VEGF Ratio Inversely to hCG in Granulosa Cells.
Miller I; Chuderland D; Ron-El R; Shalgi R; Ben-Ami I
J Clin Endocrinol Metab; 2015 Nov; 100(11):E1428-36. PubMed ID: 26308290
[TBL] [Abstract][Full Text] [Related]
4. TGF-β1 induces VEGF expression in human granulosa-lutein cells: a potential mechanism for the pathogenesis of ovarian hyperstimulation syndrome.
Fang L; Li Y; Wang S; Li Y; Chang HM; Yi Y; Yan Y; Thakur A; Leung PCK; Cheng JC; Sun YP
Exp Mol Med; 2020 Mar; 52(3):450-460. PubMed ID: 32152452
[TBL] [Abstract][Full Text] [Related]
5. Human chorionic gonadotropin-induced ovarian hyperstimulation syndrome is associated with up-regulation of vascular endothelial growth factor.
Wang TH; Horng SG; Chang CL; Wu HM; Tsai YJ; Wang HS; Soong YK
J Clin Endocrinol Metab; 2002 Jul; 87(7):3300-8. PubMed ID: 12107240
[TBL] [Abstract][Full Text] [Related]
6. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F
Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536
[TBL] [Abstract][Full Text] [Related]
7. Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats.
Ishikawa K; Ohba T; Tanaka N; Iqbal M; Okamura Y; Okamura H
Endocr J; 2003 Oct; 50(5):515-25. PubMed ID: 14614207
[TBL] [Abstract][Full Text] [Related]
8. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome.
Neulen J; Yan Z; Raczek S; Weindel K; Keck C; Weich HA; Marmé D; Breckwoldt M
J Clin Endocrinol Metab; 1995 Jun; 80(6):1967-71. PubMed ID: 7775647
[TBL] [Abstract][Full Text] [Related]
9. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
van de Lagemaat R; Raafs BC; van Koppen C; Timmers CM; Mulders SM; Hanssen RG
Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
[TBL] [Abstract][Full Text] [Related]
10. The role of IL-6 trans-signaling in vascular leakage: implications for ovarian hyperstimulation syndrome in a murine model.
Wei LH; Chou CH; Chen MW; Rose-John S; Kuo ML; Chen SU; Yang YS
J Clin Endocrinol Metab; 2013 Mar; 98(3):E472-84. PubMed ID: 23348396
[TBL] [Abstract][Full Text] [Related]
11. The role of pigment epithelium-derived factor in the pathophysiology and treatment of ovarian hyperstimulation syndrome in mice.
Chuderland D; Ben-Ami I; Kaplan-Kraicer R; Grossman H; Ron-El R; Shalgi R
J Clin Endocrinol Metab; 2013 Feb; 98(2):E258-66. PubMed ID: 23295464
[TBL] [Abstract][Full Text] [Related]
12. A potential role of endoplasmic reticulum stress in development of ovarian hyperstimulation syndrome.
Takahashi N; Harada M; Hirota Y; Zhao L; Yoshino O; Urata Y; Izumi G; Takamura M; Hirata T; Koga K; Wada-Hiraike O; Fujii T; Osuga Y
Mol Cell Endocrinol; 2016 Jun; 428():161-9. PubMed ID: 27032713
[TBL] [Abstract][Full Text] [Related]
13. In vivo intrabursal administration of bioactive lipid sphingosine-1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome.
Di Pietro M; Pascuali N; Scotti L; Irusta G; Bas D; May M; Tesone M; Abramovich D; Parborell F
Mol Hum Reprod; 2017 Jun; 23(6):417-427. PubMed ID: 28379469
[TBL] [Abstract][Full Text] [Related]
14. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
Rizk B; Aboulghar M; Smitz J; Ron-El R
Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
[TBL] [Abstract][Full Text] [Related]
15. EGR1 Promotes Ovarian Hyperstimulation Syndrome Through Upregulation of SOX9 Expression.
Wang H; Chen W; Huang Y; Sun Y; Liu Y; Zhu Y; Lu Z
Cell Transplant; 2023; 32():9636897231193073. PubMed ID: 37737125
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model.
Quintana R; Kopcow L; Marconi G; Young E; Yovanovich C; Paz DA
Fertil Steril; 2008 Oct; 90(4 Suppl):1511-6. PubMed ID: 18166186
[TBL] [Abstract][Full Text] [Related]
17. Effect and underlying mechanism of Bu-Shen-An-Tai recipe on ovarian apoptosis in mice with controlled ovarian hyperstimulation implantation dysfunction.
Ma WW; Xiao J; Song YF; Ding JH; Tan XJ; Song KK; Zhang MM
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):401-406. PubMed ID: 28585136
[TBL] [Abstract][Full Text] [Related]
18. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
Tong XM; Zhang SY; Song T; Xu WH; Lin XN; Shu J; Liu L
Chin Med J (Engl); 2008 Dec; 121(23):2434-9. PubMed ID: 19102964
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
Gómez R; Simón C; Remohí J; Pellicer A
Endocrinology; 2002 Nov; 143(11):4339-48. PubMed ID: 12399430
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of AREG, EGFR, and HER2 contributes to increased VEGF expression in granulosa cells of patients with OHSS†.
Fang L; Yu Y; Li Y; Wang S; He J; Zhang R; Sun YP
Biol Reprod; 2019 Aug; 101(2):426-432. PubMed ID: 31167229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
